Leading commercial law firm Hill Dickinson has advised Edinburgh and Leeds-based venture capital firm, Par Equity, on its leading investment into paediatric healthtech business Little Journey during a Series A funding round.
Little Journey, an innovative healthtech company transforming the delivery of paediatric care through personalised psychological support, has gained a significant financial boost of £6 million, which will be used to scale its operations globally, with a focus on the US healthcare market.
Partner Alison Starr and legal director Tamanna Keir led on the provision of legal advice to Par Equity.
We are delighted to advise Par Equity on this important investment into Little Journey, combining our company investment expertise with our leading healthtech credentials. We are pleased to be part of the team supporting high-growth companies such as Little Journey and the invaluable role that Par Equity has in supporting companies on their scale up and growth.Alison Starr
Partner
Alison Starr said: “We are delighted to advise Par Equity on this important investment into Little Journey, combining our company investment expertise with our leading healthtech credentials. We are pleased to be part of the team supporting high-growth companies such as Little Journey and the invaluable role that Par Equity has in supporting companies on their scale up and growth.”
Elizabeth Young, Investment Manager at Par Equity said: “Healthtech is at the heart of what we do at Par Equity. We are committed to supporting high-growth, impactful healthtech companies that have the potential to revolutionise the way that care is delivered. At present, there exists a pressing need for bespoke technologies tailored to children and Little Journey’s innovative approach to paediatric care does just that. We look forward to seeing what’s in store for the future of children’s healthcare and are excited to support Little Journey’s expansion into the US and beyond.”